The agreement between About NEXT Oncology, an Avacare business, and Quirónsalud Group established a research program that provides the highest possible number of early phase clinical trials in Spain, with locations in Barcelona and Madrid. It also offers quality, safety, and specialized care to patients enrolled in the trials, while thereby ensuring top-notch scientific rigor and creating opportunities to translate research findings to routine clinical practice.
Early phase clinical trials create an opportunity for patients to access new therapies that are not yet available and undergo treatment in a safe setting where they will be more closely followed throughout the trial. Additionally, early phase clinical research may have a significant impact on disease prognosis and improved outcomes for cancer patients in the future.
If you are interested in participating in trials at NEXT Oncology, please contact us to learn more.
1 Calle Diego de Velazquez 1
28223 Pozuelo de Alarcón Madrid, Spain
Phone: Dial 011 (+34) 932-381-661
Open Monday-Friday 8:00 AM to 5:00 PM
